B26-73271-44805
4 vaccinations
4 coded responses
44 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 581 / ND
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Registered in v-safe
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
-
2021-02-17
Dose 2 — Pfizer-BioNTech
- 2021-02-17
- 2021-02-18
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction, No adverse event — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: These occurred last evening. All okay this morning on arising.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-05-19
- 2021-08-18
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
-
2022-01-01
Survey response — 3 months, dose 3MedDRA: Hospitalisation, Intestinal obstruction, Pre-existing disease, SARS-CoV-2 test negative — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: In hospital with bowel obstruction. Has nothing to do with COVID. Due to previous abd surgery. Had routine COVID test on admission that was negative. · Healthcare visit (other): Bowel obstructionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-01-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-02
-
2022-04-20
Dose 4 — Pfizer-BioNTech
- 2022-05-15
- 2022-05-18
- 2022-05-25
-
2022-06-01
Survey response — day 42, dose 4MedDRA: Hyperhidrosis, Malaise, Nausea, Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: 12 hour episode of nausea and vomiting. Extreme diaphoresis accompanied episode, as well as general malaise.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-20
-
2022-10-19
Survey response — 6 months, dose 4MedDRA: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activitiesFree text: COVID early September. Husband went on Honor Flight to DC. Returned and got covid three days after returning. I had symptoms 4 days after his return and positive test .MedDRA releases: 2024-11 · check-in free text available
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): These occurred last evening. All okay this morning on arising.
Release 10 — 3 months, dose 3
Symptoms: In hospital with bowel obstruction. Has nothing to do with COVID. Due to previous abd surgery. Had routine COVID test on admission that was negative.
Healthcare visit (other): Bowel obstruction
Release 11 — day 42, dose 4
Symptoms: 12 hour episode of nausea and vomiting. Extreme diaphoresis accompanied episode, as well as general malaise.
Release 12 — 6 months, dose 4
Symptoms: COVID early September. Husband went on Honor Flight to DC. Returned and got covid three days after returning. I had symptoms 4 days after his return and positive test .
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Intestinal obstruction | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Intestinal obstruction | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release